stella
beta
An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus — Stella
Recruiting
Back to Systemic Lupus Erythematosus (SLE) trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
China
Changhai Hospital, Shanghai
View full record on ClinicalTrials.gov